Advanced Monitored Caregiving (AMC Health)
See the following -
Chip Away At The Stone: REMOTE, Transparency Life Sciences
(This blog is part 2 of my interview with Tomasz Sablinski, MD, PhD, Founder and CEO of Transparency Life Sciences. As noted in my first blog, Sablinski’s company announced it was the first company to have an IND cleared using a crowdsourced protocol. [...] Read More »
- Login to post comments
FDA Clears IND For First Clinical Trial Protocol Developed Using Crowdsourcing
Transparency Life Sciences, LLC (TLS), the world's first drug development company based on open innovation, today announced that its Investigational New Drug Application (IND) to assess lisinopril as an adjunctive therapy for multiple sclerosis (MS) has been cleared by the US Food and Drug Administration (FDA). Read More »
- Login to post comments
Trial Designed With Crowd Input Gets FDA Signoff
What's been called the first clinical study protocol developed using crowdsourcing methods received the FDA's imprimatur earlier this month. The agency approved Transparency Life Sciences' IND for a clinical trial designed to test a generic blood-pressure medication, ACE inhibitor lisinopril, in patients with relapsing remitting multiple sclerosis. Read More »
- Login to post comments